Search results with tag "Cinacalcet"
Lijst preferentiebeleid Menzis
www.menzis.nlCinacalcet Oraal 30 mg Will pharma 16867904 01.07.2020 31.12.2022 Cinacalcet Oraal 60 mg Will pharma 16867947 01.07.2020 31.12.2022 Cinacalcet Oraal 90 mg Will pharma 16867955 01.07.2020 31.12.2022 Claritromycine oraal 500 mg Aurobindo 15947173 01.01.2020 31.12.2023 Clobetasol Lokaal 0,5 mg Xiromed 16769082 01.10.2020 31.12.2022
Common Medications Taken During Hemodialysis
www.uhn.caCinacalcet (Sensipar) Some patients on hemodialysis have increased parathyroid hormone levels. If your hormone levels are high for a long time, this can lead to bone disease. First we use Calcitriol to lower the hormone. If Calcitriol does not lower your parathyroid hormone levels, then your doctor may prescribe a medication called cinacalcet.
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.pi.amgen.comlevels of cinacalcet. Dose adjustment and monitoring of iPTH serum phosphorus and serum calcium may be required. (7.1) Cinacalcet is a strong inhibitor of CYP2D6. Dose adjustments may be required for concomitant medications that are predominantly metabolized by CYP2D6. (7.2)
Updated Quarterly Comprehensive Specialty Pharmacy Drug …
www.caremark.comcinacalcet hydrochloride (sensipar) parsabiv tiopronin respiratory syncytial virus synagis rheumatoid arthritis actemra avsola cimza enbrel humira inflectra infliximab kevzara olumiant orencia otrexup rasuvo remicade renflexis rinvoq rituxan ruxience simponi simponi aria truxima xeljanz seizure disorders acthar epidiolex vigabatrin pwd (sabril
Oral Dosage Forms That Should Not be Crushed - VCHCA
hospitals.vchca.orgcinacalcet Sensipar Tablet Note: tablets are not scored and cutting may cause variable dosage accuracy cloNIDine Kapvay Tablet Slow-release - Do not crush sustained-release product - Immediate-release tablet may disperse in water (20 mL) within 5 minutes cyclophosphamide Cytoxan Tablet Note: drug may be crushed but company
Primary hyperparathyroidism PRACTICE
www.racgp.org.auCinacalcet, a calcimimetic, has been shown to normalise serum calcium but not to have any effect on bone mineral density. Medically treated patients need 6 monthly monitoring of their serum calcium, annual bone mineral densities and 24 hour urine calcium excretion. In one study at 10 year follow up of 52 asymptomatic patients
1. PRODUCT NAME - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Sensipar NZ data sheet CDS v23 Page 3 of 23 Hepatic impairment Moderate to severe hepatic impairment (Child-Pugh classification) increases cinacalcet